NDT Advance Access published online on April 19, 2005
Nephrology Dialysis Transplantation, doi:10.1093/ndt/gfh824
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 CORE Center for Outcomes Research, Basel/Binningen, Switzerland
Editorial Review
Health economics--what the nephrologist should know
This article has no Abstract.
Keywords:
cost-effectiveness; costs; health economics; modelling; nephrology; thresholds; willingness to pay.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
M. J. Postma and D. de Zeeuw The economic benefits of preventing end-stage renal disease in patients with type 2 diabetes mellitus Nephrol. Dial. Transplant., October 1, 2009; 24(10): 2975 - 2983. [Full Text] [PDF] |
||||
![]() |
M. J. Postma, C. Boersma, and R. T. Gansevoort Pharmacoeconomics in nephrology: considerations on cost-effectiveness of screening for albuminuria Nephrol. Dial. Transplant., April 1, 2008; 23(4): 1103 - 1106. [Full Text] [PDF] |
||||
